Lipid Standards

LIPID MAPS® analytical standards include

  • MS/MS spectra, including annotations for principal product ions
  • Experimental parameters used for acquisition of MS/MS spectra
  • LC retention time data for Eicosanoids
  • Links to Cayman/Avanti catalog product descriptions
  • Literature reference(s) pertaining to identification of MS product ions

 

View standards by lipid category

 

Search:

  Records per page     

Fields searched:
Name, Systematic Name (case insensitive)


This table can be scrolled horizontally if width exceeds container width.

LM ID
Name
Systematic Name
Cayman ID
Avanti ID
MS/MS
Ion
Conditions
LMGP01010001 PC(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine LM1000 Spectrum [M+H]+ Details
LMGP01010001 PC(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine LM1000 Spectrum [M.Cl]- Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine LM1002 Spectrum [M+H]+ Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine LM1002 Spectrum [M.Cl]- Details
LMGP10010003 PA(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate LM1002 Spectrum [M-H]- Details
LMGP02010003 PE(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine LM1002 Spectrum [M+H]+ Details
LMGP04010006 PG(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) LM1002 Spectrum [M-H]- Details
LMGP02010003 PE(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine LM1002 Spectrum [M-H]- Details
LMGP02010004 PE(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine LM1003 Spectrum [M-H]- Details
LMGP02010004 PE(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine LM1003 Spectrum [M+H]+ Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine LM1003 Spectrum [M.Cl]- Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine LM1003 Spectrum [M+H]+ Details
LMGP01010008 PC(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine LM1004 Spectrum [M.Cl]- Details
LMGP01010008 PC(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine LM1004 Spectrum [M+H]+ Details
LMGP02010008 PE(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphoethanolamine LM1100 Spectrum [M+H]+ Details
LMGP02010008 PE(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphoethanolamine LM1100 Spectrum [M-H]- Details
LMGP02010005 PE(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine LM1104 Spectrum [M+H]+ Details
LMGP02010005 PE(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoethanolamine LM1104 Spectrum [M-H]- Details
LMGP04010001 PG(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phospho-(1'-rac-glycerol) LM1200 Spectrum [M-H]- Details
LMGP04010007 PG(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) LM1204 Spectrum [M-H]- Details
LMGP03010001 PS(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phosphoserine LM1300 Spectrum [M-H]- Details
LMGP03010003 PS(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl, 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoserine LM1302 Spectrum [M-H]- Details
LMGP03010006 PS(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphoserine LM1304 Spectrum [M-H]- Details
LMGP06010003 PI(12:0/13:0) 1-dodecanoyl-2-tridecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) LM1500 Spectrum [M-H]- Details
LMGP06010004 PI(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1502 Spectrum [M-H]- Details
LMGP06010005 PI(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1503 Spectrum [M-H]- Details
LMGP06010006 PI(17:0/14:1(9Z)) 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1504 Spectrum [M-H]- Details
LMGP01050001 PC(13:0/0:0) 1-tridecanoyl-sn-glycero-3-phosphocholine LM1600 Spectrum [M.Cl]- Details
LMGP01050001 PC(13:0/0:0) 1-tridecanoyl-sn-glycero-3-phosphocholine LM1600 Spectrum [M+H]+ Details
LMGP01050002 PC(17:1(10Z)/0:0) 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine LM1601 Spectrum [M+H]+ Details
LMGP01050002 PC(17:1(10Z)/0:0) 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphocholine LM1601 Spectrum [M.Cl]- Details
LMGP10050002 PA(17:1(9Z)/0:0) 1-(9Z-heptadecenoyl)-sn-glycero-3-phosphate LM1701 Spectrum [M-H]- Details
LMGP07010002 PIP[3'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) LM1900 Spectrum [M-H]- Details
LMGP07010003 PIP[4'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) LM1901 Spectrum [M-H]- Details
LMGP07010004 PIP[5'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) LM1902 Spectrum [M-H]- Details
LMGP08010001 PIP2[3',4'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) LM1903 Spectrum [M-H]- Details
LMGP08010003 PIP2[4',5'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) LM1904 Spectrum [M-H]- Details
LMGP08010002 PIP2[3',5'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) LM1905 Spectrum [M-H]- Details
LMGP09010001 PIP3[3',4',5'](17:0/20:4(5Z,
8Z,11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) LM1906 Spectrum [M-H]- Details
LMSP01040002 C17 Sphingosine heptadecasphing-4-enine 10007902 LM2000 Spectrum [M-H]- Details
LMSP01040002 C17 Sphingosine heptadecasphing-4-enine 10007902 LM2000 Spectrum [M+H]+ Details
LMSP01040003 C17 Sphinganine heptadecasphinganine 22510 LM2001 Spectrum [M+H]+ Details
LMSP02010002 Ceramide Cer(d18:1/12:0) N-(dodecanoyl)-sphing-4-enine 22530 LM2212 Spectrum [M-H]- Details
LMSP02010002 Ceramide Cer(d18:1/12:0) N-(dodecanoyl)-sphing-4-enine 22530 LM2212 Spectrum [M+H]+ Details
LMSP03010002 Sphingomyelin SM(d18:1/12:0) N-(dodecanoyl)-sphing-4-enine-1-phosphocholine LM2312 Spectrum [M+H]+ Details
LMSP0501AA01 Glucosyl ceramide
GlcCer(d18:1/12:0)
N-(dodecanoyl)-1-beta-glucosyl-sphing-4-enine LM2511 Spectrum [M+H]+ Details
LMSP0501AA01 Glucosyl ceramide
GlcCer(d18:1/12:0)
N-(dodecanoyl)-1-beta-glucosyl-sphing-4-enine LM2511 Spectrum [M-H]- Details
LMSP0501AB02 Lactosyl ceramide
LacCer(d18:1/12:0)
N-(dodecanoyl)-1-b-lactosyl-sphing-4-enine LM2512 Spectrum [M-H]- Details
LMSP0501AB02 Lactosyl ceramide
LacCer(d18:1/12:0)
N-(dodecanoyl)-1-b-lactosyl-sphing-4-enine LM2512 Spectrum [M+H]+ Details
LMST01010018 25-hydroxy-cholesterol cholest-5-en-3beta,25-diol 11097 Spectrum [M+NH4]+ Details

Number of records: 481

next 50 records